Estimated costs of foodborne infections 140 million euros lower in 2020 In 2020, the estimated costs of foodborne infections in the Netherlands were 140 million euros lower than in the preceding year. This corresponds to a 30% decrease. ANP
Wider availability of self-tests leads to higher willingness to test As of Friday 3 December, the recommendation in the Netherlands is to use a self-test in case of mild symptoms, as an alternative to a test by the Municipal Public Health Services (GGDs). Beeld: ANP
Healthcare utilisation increases with Long COVID symptoms More than 15,000 people are taking part in the LongCOVID study conducted by RIVM. Participants with existing long-term symptoms after COVID-19 (Long COVID) reported higher healthcare utilisation.
Situation growing worse in the Netherlands In the week from 17 to 23 March, 46,005 people received a positive test result for COVID-19, an increase of 16% compared to the week before that. The reproduction number continued to rise, from 1.06 on 1 March to 1.11 on 8 March.
Number of positive COVID-19 tests at the same level as last week In the week from 2 to 9 March, 31,959 people received a positive test result for COVID-19, about the same as in the week before that. More than 360,000 people were tested, an increase of nearly 14% compared to the week before that.
Policy on coronavirus measures causes friction, but compliance is still high for now Compliance with the coronavirus measures in the Netherlands, such as the night-time curfew, working from home and avoiding crowds, is still high.
First clients and care workers in mental healthcare vaccinated on Monday The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.
New research in GGD test lanes on spread of coronavirus SARS-CoV-2 RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.